Significant progress against post-COVID-19 growth strategy to offset expected decline in COVID-19 sales Paris, France and Camberley, UK – 29 September 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international...
https://novacyt.com/wp-content/uploads/2022/09/Notice-of-HY22-Results-15.09.2022.pdf Paris, France and Camberley, UK – 15 September 2022 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it will report its unaudited...
New freeze-dried, direct-to-PCR assays extend the global reach of Novacyt’s PCR portfolio with ability to be transported at ambient temperatures Two PROmate® lyophilised assays initially launched for COVID-19, with a broader...
The assay has been developed by Novacyt to support research efforts following a recent increase in cases of acute hepatitis in children Paris, France and Camberley, UK – 28 July...
Paris, France and Camberley, UK – 20 July 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that all resolutions proposed at the ordinary...
Paris, France and Camberley, UK – 15 July 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it has been notified that, on...
Paris, France and Camberley, UK – 15 July 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s exsig™ COVID-19 Direct Real-Time...
Paris, France and Camberley, UK – 7 July 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces a trading update for the half year...
Paris, France and Camberley, UK – 5 July 2022 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified by Biosynex...
Paris, France and Camberley, UK – 28 June 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the launch of its research-use-only (RUO) polymerase...
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
